The Market Reports

Synopsis
The global market for Ibuprofen API was estimated to be worth US$ 749 million in 2024 and is forecast to a readjusted size of US$ 1074 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Ibuprofen (API), also known as ibuprofen, is a non-steroidal anti-inflammatory drug for antipyretics and analgesia. It has good anti-inflammatory, analgesic and antipyretic effects. Compared with general anti-inflammatory and analgesic drugs, it has strong effects and few side effects. It has no obvious side effects on the liver, kidneys and hematopoietic system, especially the gastrointestinal tract. At present, ibuprofen has been included in the pharmacopoeias of many countries such as China, the United States, the United Kingdom, Japan, and the European Pharmacopoeia. It has been widely used around the world and has become one of the world's best-selling over-the-counter drugs.
The Ibuprofen API (Active Pharmaceutical Ingredient) market is primarily driven by the increasing global demand for pain relief and anti-inflammatory medications. Ibuprofen is one of the most commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) for treating conditions such as arthritis, fever, headaches, menstrual pain, and other types of mild to moderate pain. The rising prevalence of chronic conditions, such as osteoarthritis and other inflammatory diseases, is driving the demand for Ibuprofen APIs. Additionally, the growing aging population and increasing awareness about over-the-counter (OTC) pain relief medications have contributed to the market's expansion. Manufacturers are also benefiting from the widespread availability of generic Ibuprofen formulations, which have made the drug more accessible and affordable.
However, the market faces challenges related to regulatory scrutiny and competition in the generic drug market. The production of Ibuprofen APIs requires strict compliance with regulatory standards, and companies must invest in quality control to ensure the safety and efficacy of the product. Furthermore, the generic nature of Ibuprofen leads to intense price competition among manufacturers, squeezing profit margins and making it difficult for companies to maintain market share. Another challenge is the rising concern about the side effects of prolonged Ibuprofen use, such as gastrointestinal issues and cardiovascular risks, which may impact consumer confidence and demand in the long term.
Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.
This report aims to provide a comprehensive presentation of the global market for Ibuprofen API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ibuprofen API by region & country, by Type, and by Application.
The Ibuprofen API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ibuprofen API.
Market Segmentation
By Company
IOLCP
SOLARA
Shandong Xinhua Pharmaceutical
Biocause
BASF
SI Group
Segment by Type
USP
EP
Segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ibuprofen API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ibuprofen API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ibuprofen API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index